Skip to main content
    L

    Lifestance Health Group Inc (LFST)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $14.48
    +0.40 (+2.84%)

    Market Cap: $5.35B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Lifestance Health Group Inc (LFST) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Lifestance Health Group (LFST) to earn $0.40 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.75B. Of 11 analysts, 9 rate the stock Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 3 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 11 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 82% of the ratings.

    RatingAnalystsShare
    Strong Buy218.2%
    Buy763.6%
    Hold218.2%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    11

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 12.5% and revenue estimates rise 13.1%.

    Fiscal year ending Dec 31, 2026
    $0.40
    EPS consensus, revenue $1.75B
    Fiscal year ending Dec 31, 2027
    $0.45
    EPS consensus, revenue $1.98B

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.40$0.40 to $0.424$1.75B$1.71B to $1.76B10
    Dec 31, 2027$0.45$0.38 to $0.515$1.98B$1.94B to $2.01B10

    Quarterly Estimates

    The EPS consensus rises from $0.04 for the quarter ending Dec 31, 2026 to $0.10 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.04$0.02 to $0.0613$462.39M$433.95M to $483.64M11
    Mar 31, 2027$0.10$0.09 to $0.112$462.50M$457.25M to $466.61M3

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 6 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202630
    Fiscal year ending Dec 31, 202710
    Quarter ending Mar 31, 202720

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 2.4% from $0.41.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$0.40$0.36$0.36$0.40$0.41-2.6%
    Fiscal year ending Dec 31, 2027$0.45$0.43$0.43$0.53$0.52-14.1%
    Quarter ending Mar 31, 2027$0.10$0.10$0.10$0.10$0.10-0.5%

    Frequently Asked Questions About LFST

    What is the LFST stock forecast?

    Consensus analyst estimates put Lifestance Health Group's EPS at $0.40 for the fiscal year ending Dec 31, 2026, on revenue of $1.75B. The consensus rating from 11 analysts is Buy.

    How do analysts rate LFST stock?

    Of 11 analysts covering Lifestance Health Group, 2 rate it Strong Buy, 7 Buy, 2 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from LFST next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.40, with estimates from $0.40 to $0.42 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.45, with estimates from $0.38 to $0.51 from 5 analysts.

    What revenue do analysts expect from Lifestance Health Group next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.75B, with estimates from $1.71B to $1.76B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.98B, with estimates from $1.94B to $2.01B.

    How many analysts cover LFST?

    11 analysts rate Lifestance Health Group stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.